l 670596 has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colombo, M; Dho, L; Pierucci, L; Rosa, B; Salvati, P; Ukmar, G; Vaghi, F; Volpi, D | 1 |
| Dho, L; Patrono, C; Rimoldi, O; Salvati, P; Ukmar, G; Vaga, L | 1 |
2 other study(ies) available for l 670596 and Disease Models, Animal
| Article | Year |
|---|---|
Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Topics: Animals; Aorta; Aspirin; Blood Platelets; Carbazoles; Coronary Thrombosis; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Guinea Pigs; Humans; Imidazoles; Male; Pentanoic Acids; Platelet Aggregation; Pyridines; Rabbits; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane-A Synthase | 1993 |
A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
Topics: Animals; Carbazoles; Carotid Artery Thrombosis; Copper; Coronary Thrombosis; Disease Models, Animal; Dogs; Evaluation Studies as Topic; Imidazoles; Male; Naphthalenes; Platelet Aggregation; Prostaglandin H2; Prostaglandins H; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1994 |